While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Residency program directors offer advice to medical residents, emphasizing that it’s okay to be unsure, explore different ...

I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.

The possession, sale, and production of psilocybin for recreational use are illegal in Canada. Why then, do brick-and-mortar ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Researchers conducted a prospective, longitudinal cohort study involving individuals with current or former habit, who had ...

The first prospective study to look at this problem since investigators identified an issue earlier confirmed that clinicians ...

Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

Early introduction of atorvastatin in patients with hypertension demonstrates sustained cardiovascular benefits, a 20-year ...

Nearly three quarters of women and people assigned female at birth experience at least one reproductive health issue, with ...